Articles tagged with: pre-exposure prophylaxis (PrEP)

GIPA takes a hit

published: September, 20, 2017 Written by // Bob Leahy - Publisher Categories // Social Media, featured, As Prevention , Activism, Current Affairs, Treatment Guidelines -including when to start, General Health, Health, Treatment, Living with HIV, Media, Opinion Pieces, Bob Leahy - Publisher

As funding starts to slow, engagement and involvement of people living with HIV is often the first to go. Bob Leahy on the politics of inclusion, exclusion and how people living with HIV are fighting back

GIPA takes a hit

“It was the best of times; it was the worst of times: said Charles Dickens. “It was the age of wisdom, it was the age of foolishness, it was the epoch of belief, it was the epoch of incredulity." That was about Paris in 1869. It could have been written about Canada in 2017 and the state of our response to HIV. The best of times? Many feel we are approaching the end of the epidemic with 2030 set as the target date by UNAIDS. We are closing in on 90-90-90 targets which means more people li

New US PrEP cost-effectiveness model finds drug prices will need to drop substantially if HIV risk rises, or if adherence is only moderate

published: September, 19, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , African, Caribbean and Black, Gay Men, Youth, Treatment Guidelines -including when to start, Women, International , Treatment, Media, Revolving Door, Guest Authors

"With high adherence, PrEP saves money in high-prevalence populations even at current costs." From AIDSmap, Gus Cairns reports.

New US PrEP cost-effectiveness model finds drug prices will need to drop substantially if HIV risk rises, or if adherence is only moderate

A new US model of the cost-effectiveness of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM), prepared by researchers at Emory University in Atlanta, finds that taking even one year of PrEP is more cost-effective than measures like kidney dialysis, if it is used by people belonging to populations where HIV prevalence is at least 10%. However, for PrEP to actually save money, relative to the lifetime cost of treating the HIV infections that would otherwise happen, either

Kenya at the forefront in tackling HIV

published: September, 13, 2017 Written by // Kimutai Kemboi, Categories // Social Media, As Prevention , Activism, African, Caribbean and Black, Kimutai Kemboi, Youth, Treatment Guidelines -including when to start, General Health, Health, International , Treatment, Living with HIV, Media, Opinion Pieces

From Kenya, HIV activist and stigma fighter Kimutai Kemboi on the initiatives the Kenyan government has taken together with other stakeholders in the struggle against HIV.

Kenya at the forefront in tackling HIV

Kenya, as a developing country, is among the African countries on the forefront in tackling HIV as well as investing personnel and resources. The government and the stake holders have done a lot though more needs to be done. The Kenyan government has given a favourable environment to stakeholders who wish to partake in this battle. Many organizations have set up facilities that offer HIV related services to people from the marginalised classes of life such as rural and slum populations. The s

No ordinary affair. IAS 2017 report from Paris, Part One: Conference highlights

published: August, 01, 2017 Written by // Bob Leahy - Publisher Categories // International AIDS Conference , Activism, Living with HIV, Bob Leahy - Publisher

Bob Leahy was in Paris last week covering the big IAS conference on HIV Science. Turns out it was the best he had been to and not just because Undetectable=Untransmittable (U=U) almost stole the show. Here is what else happened.

No ordinary affair. IAS 2017 report from Paris, Part One: Conference highlights

International AIDS Society Conferences come in two sizes. They alternate. Next year will be the big one in Amsterdam which deals with the whole panoply of HIV knowledge, including science and research and more. It will likely attract about 20,000 people. This year’s alternate year conference was just about HIV science, a smaller affair with 8,000 or so of us in attendance from 40 countries with an agenda less community-based. In other words, it was potentially a bit dull. This one certainl

Kenya as far as Undetectable equals Untransmittable (U=U) is concerned

published: July, 26, 2017 Written by // Kimutai Kemboi, Categories // Social Media, As Prevention , Activism, African, Caribbean and Black, Kimutai Kemboi, Treatment Guidelines -including when to start, Health, International , Treatment, Living with HIV, Media, Opinion Pieces, Population Specific

From Kenya, Kimutai Kemboi on the achievements and the challenges Kenya faces going forward in the fight against HIV.

Kenya as far as Undetectable equals Untransmittable (U=U) is concerned

As a developing country, Kenya still faces a number of challenges in almost all sectors, including the health sector. This poses a great threat when it comes to addressing health related issues. Such challenges include shortage of funds, inadequate specialized equipment among other things. Despite these difficulties, the Government of Kenya has put in place policies favoring activities that boost provision of health care services. These include a National Health Insurance Fund run by the gove

I made an HIV prevention video for guys who hate condoms. Here’s why (NSFW)

published: July, 18, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Alternative Therapies, As Prevention , African, Caribbean and Black, Gay Men, Youth, Treatment Guidelines -including when to start, General Health, Health, Treatment, Media, Revolving Door, Guest Authors

“I thought that we needed something bolder, something sexier, and something that reflected the realities of gay sex...”

I made an HIV prevention video for guys who hate condoms. Here’s why (NSFW)

Mr. Leather LA 2014 and LA County HIV Commission member Eric Paul Leue    Photo: John Kiffmeyer To read the complete article by Chris Tipton-King visit Huffington Post, here. If you weren’t aware that Gilead recently started running Truvada for PrEP ads, I wouldn’t blame you: they’re exactly the sort of vanilla, stock-photo-and-fine-print yawners that you might expect from a pharmaceutical company. For a prevention strategy meant for men who enjoy dicks in butts au-natural, most

‘Blood disgust’ is nothing new to people with HIV

published: July, 12, 2017 Written by // Mark S. King - My Fabulous Disease Categories // Social Media, Gay Men, Mental Health, Health, International , Living with HIV, Media, Opinion Pieces, Population Specific , Mark S. King

Mark S. King: "Unrealistic fear of HIV blood isn’t limited to the history books. HIV criminalization... preys upon outdated fears and public disgust with people living with the virus."

‘Blood disgust’ is nothing new to people with HIV

It is coursing through our veins, sustaining life and fighting disease, and yet we fear it. The sight of a few drops can make an adult faint. A bucket of it in a movie is the very definition of horror. Even as Donald Trump contributes his perverted, sexist new layer of blood revulsion (through a history of insults that include journalist Megyn Kelly’s bloody “whatever” and his most recent fabrication about a “bleeding” face lift that cable news anchor Mika Brzezinski never had)

We've got the tools right now. Let's end the HIV epidemic.

published: July, 10, 2017 Written by // T.J. Miller Categories // Aging, Social Media, As Prevention , T.J. Miller, Activism, Gay Men, Treatment Guidelines -including when to start, Health, International , Treatment, Living with HIV, Media, Opinion Pieces

"I was on the front lines of the battle in the early days, and I still am on the battle lines today as an advocate." PositiveLite.com welcomes longtime health care provider and HIV advocate T. J. Miller.

We've got the tools right now. Let's end the HIV epidemic.

This was the first article that appeared in the New York Times, that told us about the devastation, the Hell that was to come. 35 years later, while we have treatments, preventative medications (PrEP) and now concrete scientific evidence that persons with HIV who have an undetectable viral load for six months or greater are unable to transmit the virus to sexual partners (Undetectable=Untransmittable/Treatment as Prevention or TasP) we are still suffering with stigma, arguing over funding, de

Surprise FDA approval of generic Truvada is a 'wakeup call' for activists

published: July, 10, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Activism, African, Caribbean and Black, Gay Men, Treatment Guidelines -including when to start, Current Affairs, Women, International , Treatment, Media, Revolving Door, Guest Authors

Advocates and doctors are scrambling to understand exactly when the generic will become available and how much it will cost. From TheBody.com, Sony Salzman reports.

Surprise FDA approval of generic Truvada is a 'wakeup call' for activists

To read the complete article by Sony Salzman, vsit TheBody.com, here. The surprise approval of generic Truvada (tenofovir disoproxil fumarate and emtricitabine) by the U.S. Food and Drug Administration (FDA) on June 9 left patients, advocates and doctors scrambling to understand exactly when the generic will become available and how much it will cost. After weeks of speculation, both of those questions remain unanswered -- locked behind a confidential settlement agreement between TEVA,

“I would not have consented to sex had I known of their HIV status.” This statement is problematic and here’s why.

published: July, 05, 2017 Written by // Samantha Categories // Social Media, Conferences, Current Affairs, Mental Health, Women, Legal, Living with HIV, Media, Opinion Pieces, Population Specific , Samantha

"How can the general public insist upon disclosure when they set the tone and grounds for unsuccessful disclosure?" Samantha offers her takeaway from " Rethinking Justice: the 7th Symposium on HIV Law and Human Rights."

 “I would not have consented to sex had I known of their HIV status.” This statement is problematic and here’s why.

On June 15, 2017 the Canadian HIV/AIDS Legal Network held a symposium in Toronto, Ontario, Rethinking Justice: the 7th Symposium on HIV Law and Human Rights. The symposium focused on unjust HIV criminal legislation in Canada. Canada unfortunately has one of the worst records in the world for the overly broad use of criminal laws to address HIV nondisclosure. Panels of experts and those with lived experience of HIV criminalization presented their research and experiences. The legal experts di

[12 3 4 5  >>